Epilepsy Overview
Despite its common incidence, epilepsy continues to be a brain disorder shrouded in mystery and misconceptions. It is estimated that in Canada there are 15,500 new cases per year. This number could be much higher as stigma often prevents individuals with epileptic symptoms from seeking treatment.
Effective approaches for diagnosing and managing epilepsy are available at the Krembil Neuroscience Centre (KNC). We recognize the challenges and unique needs of epilepsy patients and are making significant strides in developing better treatments and increasing access to care through innovative research.
KNC is home to the province’s first Gamma Knife – also known as radiosurgery – a non-invasive treatment effective for inaccessible brain tumours, chronic pain and movement disorders. The Centre is evaluating radiosurgery as a possible new treatment for epilepsy.
KNC is pioneering research in Deep Brain Stimulation (DBS) for a variety of neurological conditions such as Parkinson’s Disease and depression. Initial studies suggest that DBS can also be effective in reducing in the number of epileptic seizures.
For patients who do not respond to medication, brain surgery can be an effective alternative. Candidates for surgery require specialized evaluation, which is performed at Toronto’s only adult Epilepsy Monitoring Unit (EMU), located at KNC.
Without treatment, epilepsy can have severe physical, emotional and social consequences. Our goal is to lessen the impact of seizures on patients through effective evaluation and treatment. Donor-supported research is essential for the advancement of innovative patient care. With your help, we can ensure that epilepsy patients receive the care they need to live productive, healthy lives.
There’s always an answer. We’ll find it.
Opportunities to support epilepsy care include supporting our researchers and educators through endowed Chairs, Fellowships and other research funds. Your gift will have a direct impact on programs that improve patients’ lives.
For more information on how you can help us find the answers, please contact:
Stuart McBurnie
Director Campaigns, Movement Disorders, Epilepsy and Psychiatry
Toronto General & Western Hospital Foundation
T: 416-603-5800 ext 3270
E: stuart.mcburnie@uhn.on.ca
